LEADER 01821nam a2200445 i 4500001    99123212193506421
005    20231117181843.0
006    m     o  d f
007    cr |||||||||||
008    201214s2020    dcu     ob   f000 0 eng c
035    on1226697468
035    (NjP)12321219-princetondb
035     |z(NjP)Voyager12321219
040    GPO |beng |erda |epn |cGPO |dMvI
042    pcc
043    n-us---
049    DOCS
074    0535 (online)
086 0  FT 1.2:B 52
090    Electronic Resource
110 1  United States. |bFood and Drug Administration, |eauthor.
245 10 Joint statement of the Food & Drug Administration and the Federal Trade Commission regarding a collaboration to advance competition to the biologic marketplace.
264  1 [Washington, D.C.] : |b[Federal Trade Commission], |c2020.
300    1 online resource (6 pages)
336    text |btxt |2rdacontent
337    computer |bc |2rdamedia
338    online resource |bcr |2rdacarrier
500    "February 3, 2020."
504    Includes bibliographical references.
588    Description based on online resource, PDF version; title from caption (FTC, viewed Dec. 11, 2020).
610 10 United States. |bFood and Drug Administration |xRules and practice.
610 10 United States. |bFederal Trade Commission |xRules and practice.
650  0 Biological products |xMarketing |xLaw and legislation |zUnited States.
650  0 Consumer protection |xLaw and legislation |zUnited States.
650  0 Advertising |xDrugs |xLaw and legislation |zUnited States.
650  0 Competition |zUnited States.
710 1  United States. |bFederal Trade Commission, |eauthor.
922    BIBCONEW |b20201214
945    DOCS |cFT 1.2:B 52
956 40  |uhttps://purl.fdlp.gov/GPO/gpo148772